Lea Hachigian - Profile and Investment Details

Investor Profile

Lea Hachigian is a Venture Capital based in Brookline, Massachusetts, United States with a diverse investment portfolio that includes companies such as Lassen Therapeutics, Pulmocide, Mitobridge, Verastem Oncology, Alnara Pharmaceuticals, Immunitas Therapeutics, Colorescience, Calithera Biosciences, Bicycle Therapeutics, PTC Therapeutics, Flex Pharma, ArcherDX, Sitryx Therapeutics, KalVista Pharmaceuticals, ImmuneID, XyloCor Therapeutics, Werewolf Therapeutics, Renovia, Grail, Axial Biotherapeutics, Channel Medsystems, IlluminOss Medical, Millendo Therapeutics, Be Biopharma, Twentyeight-Seven Therapeutics, Recros Medica, TScan Therapeutics, Pyxis Oncology, . Over time, Lea Hachigian has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Lea Hachigian is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Wellness, Women Founded, Life Science, Engineering, Biotechnology, Drug Development, Clinical Trials, Research, Health Diagnostics, Medical, B2B, Therapeutics, Personal Health, Pharmaceuticals may find it worthwhile to explore potential connections with Lea Hachigian, as their portfolio suggests a familiarity and interest in this area.

Understanding Lea Hachigian’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.